Loading...
XNAS
MXCT
Market cap137mUSD
Aug 28, Last price  
1.22USD
Name

MaxCyte Inc

Chart & performance

D1W1MN
XNAS:MXCT chart
P/E
P/S
3.96
EPS
Div yield, %
Shrs. gr., 5y
8.91%
Rev. gr., 5y
4.76%
Revenues
Net income
CFO

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products consists of ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. It also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.
IPO date
Mar 29, 2016
Employees
125
Domiciled in
US
Incorporated in
US

Valuation

No data to show